Perlecan: A major IL-2-binding proteoglycan in murine spleen

Immunology and Cell Biology

Volumn 86, Issue 2, 2008, Pages 192-199

  Miller, John D ^a,d   Stevens, Elliott T ^b   Smith, Deandra R ^a   Wight, Thomas N ^c   Wrenshall, Lucile E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Extracellular matrix; Heparan sulfate; Interleukin 2; Murine; Spleen

Indexed keywords

INTERLEUKIN 2; PERLECAN; PROTEOHEPARAN SULFATE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PROTEIN BINDING; SPLEEN;

ANIMALS; CELL PROLIFERATION; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; INTERLEUKIN-2; MICE; SPLEEN;

MURINAE;

EID: 39749186044     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100128     Document Type: Article

References (44)

1. Proudfoot AE. The biological relevance of chemokine-proteoglycan interactions. Biochem Soc Trans 2006; 34: 422-426.
2. Yamashita K, Fukushima K. The carbohydrate recognition by cytokines modulates their physiological activities. Glycoconj J 2004; 21: 31-34.
3. Wrenshall LE, Platt JL, Stevens ET, Wight TN, Miller JD. Propagation and control of T cell responses by heparan sulfate-bound IL-2. J Immunol 2003; 170: 5470-5474.
4. Esko JD, Lindahl U. Molecular diversity of heparan sulfate. J Clin Invest 2001; 108: 169-173.
5. Nugent MA. Heparin sequencing brings structure to the function of complex oligosaccharides. Proc Natl Acad Sci USA 2000; 97: 10301-10303.
6. Iozzo RV. Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 2001; 108: 165-167.
7. Ali S, Hardy LA, Kirby JA. Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans? Transplantation 2003; 75: 1773-1782.
8. Kodaira Y, Platt JL. Modification of antigen-presenting cell functions by heparan sulfate. Transplantation Proc 2000; 32: 947.
9. Wrenshall LE, Platt JL. Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J Immunol 1999; 163: 3793-3800.
10. Wrenshall LE, Cerra FB, Singh RK, Platt JL. Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes. J Immunol 1995; 154: 871-880.
11. Wrenshall LE, Cerra FB, Rubinstein P, Platt JL. Regulation by heparan sulfate and interleukin 1 alpha of the ontogenic expression of T-cell receptor, CD4, and CD8 in developing thymus. Hum Immunol 1993; 38: 165-171.
12. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988; 332: 376-378.
13. Lortat-Jacob H, Garrone P, Banchereau J, Grimaud JA. Human interleukin 4 is a glycosaminoglycan-binding protein. Cytokine 1997; 9: 101-105.
14. Lipscombe RJ, Nakhoul AM, Sanderson CJ, Coombe DR. Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix. J Leukoc Biol 1998; 63: 342-350.
15. Mummery RS, Rider CC. Characterization of the heparin-binding properties of IL-6. J Immunol 2000; 165: 5671-5679.
16. Clarke D, Katoh O, Gibbs RV, Griffiths SD, Gordon MY. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance. Cytokine 1995; 7: 325-330.
17. Goger B, Halden Y, Rek A, Mösl R, Pye D, Gallagher J et al. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 2002; 41: 1640-1646.
18. Salek-Ardakani S, Arrand JR, Shaw D, Mackett M. Heparin and heparan sulfate bind interleukin-10 and modulate its activity. Blood 2000; 96: 1879-1888.
19. Lortat-Jacob H, Esterre P, Grimaud JA. Interon-gamma, an anti-fibrogenic cytokine which binds to heparan sulfate. Pathol Res Pract 1994; 190: 920-922.
20. Ali S, Fritchley SJ, Chaffey BT, Kirby JA. Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration. Glycobiology 2002; 12: 535-543.
21. Chakravarty L, Rogers L, Quach T, Breckenridge S, Kolattukudy PE. Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J Biol Chem 1998; 273: 29641-29647.
22. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992; 119: 961-975.
23. Iozzo RV. Perlecan: a gem of a proteoglycan. Matrix Biol 1994; 14: 203-208.
24. Asundi VK, Carey DJ. Self-association of N-syndecan (syndecan-3) core protein is mediated by a novel structural motif in the transmembrane domain and ectodomain flanking region. J Biol Chem 1995; 270: 26404-26410.
25. Miller JD, Cummings J, Maresh GA, Walker DG, Castillo GM, Ngo C et al. Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus. Glia 1997; 21: 228-243.
26. Saunders S, Bernfield M. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix. J Cell Biol 1988; 106: 423-430.
27. Choi S, Lee E, Kwon S, Park H, Yi JY, Kim S et al. Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4. J Biol Chem 2005; 280: 42573-42579.
28. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992; 8: 365-393.
29. Fukushima K, Yamashita K. Interleukin-2 carbohydrate recognition modulates CTLL-2 cell proliferation. J Biol Chem 2001; 276: 7351-7356.
30. Fukushima K, Hara-Kuge S, Ideo H, Yamashita K. Carbohydrate recognition site of interleukin-2 in relation to cell proliferation. J Biol Chem 2001; 267: 31202-31208.
31. Argyris EG, Kulkosky J, Meyer ME, Xu Y, Mukhtar M, Pomerantz RJ et al. The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity. Virology 2004; 330: 481-486.
32. Sharma B, Handler M, Eichstetter I, Whitelock JM, Nugent MA, Iozzo RV. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest 1998; 102: 1599-1608.
33. Whitelock JM, Graham LD, Melrose J, Murdoch AD, Iozzo RV, Underwood PA. Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol 1999; 18: 163-178.
34. Lyons AB, Parish CR. Are murine marginal-zone macrophages the splenic white pulp analog of high endothelial venules? Eur J Immunol 1995; 25: 3165-3172.
35. Brelinska R, Pilgrim C, Reisert I. Pathways of lymphocyte migration within the periarterial lymphoid sheath of rat spleen. Cell Tissue Res 1984; 236: 661-667.
36. Lo CG, Lu TT, Cyster JG. Integrin-dependence of lymphocyte entry into the splenic white pulp. J Exp Med 2003; 197: 353-361.
37. Parish CR. The role of heparan sulfate in inflammation. Nat Rev Immunol 2006; 6: 633-643.
38. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J 1997; 11: 51-59.
39. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA. The degredation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 1996; 271: 10079-10086.
40. Rauch BH, Millette E, Kenagy RD, Daum G, Fischer JW, Clowes AW. Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem 2005; 280: 17501-17511.
41. Hassell JR, Leyshon WC, Ledbetter SR, Tyree B, Suzuki S, Kato M et al. Isolation of two forms of basement membrane proteoglycans. J Biol Chem 1985; 260: 8098-8105.
42. Fransson LA, Rodén L, Spach ML. Automated ion-exchange chromatography of uronic acids and uronic acid containing oligosaccharides. Anal Biochem 1968; 21: 317-330.
43. Couchman JR, Caterson B, Christner JE, Baker JR. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature 1984; 307: 650-652.
44. Giglia JS, Ovak GM, Yoshida MA, Twist CJ, Jeffery AR, Pauly JL. Isolation of mouse T-cell lymphoma lines from different long-term interleukin 2-dependent cultures. Cancer Res 1985; 45: 5027-5034.